Qualitic


Startup developing a rapid, low-cost paper-based screening test for Clostridioides difficile intended for point-of-care use. Work includes assay and device development, early-stage testing, academic and hospital partnerships, NIH-sponsored research, and plans for clinical trials and regulatory submission.

Industries

biotechnology
health-diagnostics

Nr. of Employees

small (1-50)


Patents

Rapid colorimetric diagnostic test for C. difficile

US-11597961-B2

View Details

Products

Rapid paper-based C. difficile screening card

A paper-based screening card that uses an oxidation–reduction color change to indicate presence of C. difficile; designed for point-of-care use without laboratory equipment and with a visual readout in under one minute.


Services

Partnerships with hospitals and academic centers to run clinical studies and gather evidence for the screening device.

Management of grant-funded research projects, including NIH-sponsored work and preparation for additional grant applications.

Expertise Areas

  • Point-of-care diagnostic development
  • Assay development and optimization
  • Clinical trial planning and hospital partnerships
  • Infectious disease diagnostics (C. difficile)
  • Show More (4)

Key Technologies

  • Paper-based colorimetric assays
  • Oxidation–reduction colorimetric chemistry
  • Point-of-care rapid diagnostics (equipment-free)
  • Low-resource diagnostic design
  • Show More (1)

News & Updates

Placed 2nd at the Atlanta Center for Microsystems Engineered Point-of-care Technologies Pitch Competition.

Completed the Georgia Tech Create-X startup launch program.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.